References
- Ahmed, M. F.; Youns, M. Synthesis and Biological Evaluation of a Novel Series of 6,8-Dibromo-4(3H)quinazolinone Derivatives as Anticancer Agents. Arch. Pharm. Chem. Life. Sci. 2013, 346, 610–617. https://doi.org/10.1002/ardp.201300158.
- Stewart, B. W.; Wild, C. W. World Cancer Report 2014, International Agency for Research on Center. World Health Organization: Lyon, 2014.
- Lal, J.; Gupta, S. K.; Thavaselvam, D.; Agarwal, D. D. Biological Activity, Design, Synthesis and Structure Activity Relationship of Some Novel Derivatives of Curcumin Containing Sulfonamides. Eur. J. Med. Chem. 2013, 64, 579–588. https://doi.org/10.1016/j.ejmech.2013.03.012.
- Konda, S.; Raparthi, S.; Bhaskar, K.; Munaganti, R. K.; Guguloth, V.; Nagarapu, L.; Akkewar, D. M. Synthesis and Antimicrobial Activity of Novel Benzoxazine Sulfonamide Derivatives. Bioorg. Med. Chem. Lett. 2015, 25, 1643–1646. https://doi.org/10.1016/j.bmcl.2015.01.026.
- Ghorab, M. M.; Ceruso, M.; Alsaid, M. S.; Nissan, Y. M.; Arafa, R. K.; Supuran, C. T. Novel Sulfonamides Bearing Pyrrole and Pyrrolopyrimidine Moieties as Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxic Activity and Molecular Modeling. Eur. J. Med. Chem. 2014, 87, 186–196. https://doi.org/10.1016/j.ejmech.2014.09.059.
- Pingaew, R.; Mandi, P.; Prachayasittikul, V.; Prachayasittikul, S.; Ruchirawat, S.; Prachayasittikul, V. Synthesis, Molecular Docking, and QSAR Study of Sulfonamide-Based Indoles as Aromatase Inhibitors. Eur. J. Med. Chem. 2018, 143, 1604–1615. https://doi.org/10.1016/j.ejmech.2017.10.057.
- Devender, N.; Gunjan, S.; Tripathi, R.; Tripathi, R. P. Synthesis and Antiplasmodial Activity of Novel Indoleamide Derivatives Bearing Sulfonamide and Triazole Pharmacophores. Eur. J. Med. Chem. 2017, 131, 171–184. https://doi.org/10.1016/j.ejmech.2017.03.010.
- Banuppriya, G.; Sribalan, R.; Padmini, V. Synthesis and Characterization of Curcumin-Sulfonamide Hybrids: Biological Evaluation and Molecular Docking Studies. J. Mol. Struct. 2018, 1155, 90–100. https://doi.org/10.1016/j.molstruc.2017.10.097.
- Poudapally, S.; Battu, S.; Velatooru, L. R.; Bethu, M. S.; Rao, J. V.; Sharma, S.; Sen, S.; Pottabathini, N.; Iska, V. B. R.; Katangoor, V. Synthesis and Biological Evaluation of Novel Quinazoline-Sulfonamides as Anti-Cancer Agents. Bioorg. Med. Chem. Lett. 2017, 27, 1923–1928. https://doi.org/10.1016/j.bmcl.2017.03.042.
- Shao, T.; Wang, J.; Chen, J. G.; Wang, X. M.; Li, H.; Li, Y. P.; Li, Y.; Yang, G. D.; Mei, Q. B.; Zhang, A. Q. Discovery of 2-Methoxy-3-Phenylsulfonamino-5-(quinazolin-6-yl or Quinolin-6-yl)benzamides as Novel PI3K Inhibitors and Anticancer Agents by Bioisostere. Eur. J. Med. Chem. 2014, 75, 96–105. https://doi.org/10.1016/j.ejmech.2014.01.053.
- Li, H.; Wang, X. M.; Wang, J.; Shao, T.; Li, Y. P.; Mei, Q. B.; Lu, S. M.; Zhang, S. Q. Combination of 2-Methoxy-3-Phenylsulfonylaminobenzamide and 2-Aminobenzothiazole to Discover Novel Anticancer Agents. Bioorg. Med. Chem. 2014, 22, 3739–3748. https://doi.org/10.1016/j.bmc.2014.04.064.
- De Souza, A. R.; Reig, M.; Bruix, J. Systemic Treatment for Advanced Hepatocellular Carcinoma: The Search of New Agents to Join Sorafenib in the Effective Therapeutic Armamentarium. Expert Opin. Pharmacother. 2016, 17, 1923–1936. https://doi.org/10.1080/14656566.2016.1225722.
- Howard, S.; Berdini, V.; Boulstridge, J. A.; Carr, M. G.; Cross, D. M.; Curry, J.; Devine, L. A.; Early, T. R.; Fazal, L.; Gill, A. L.; Heathcote, M.; Maman, S.; Matthews, J. E.; McMenamin, R. L.; Navarro, E. F.; O'Brien, M. A.; O'Reilly, M.; Rees, D. C.; Reule, M.; Tisi, D.; Williams, G.; Vinković, M.; Wyatt, P. G. Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity. J. Med. Chem. 2009, 52(2), 379–388. https://doi.org/10.1021/jm800984v.
- Gopalsamy, A.; Yang, H.; Ellingboe, J. W.; Tsou, H. R.; Zhang, N.; Honores, E.; Powell, D.; Miranda, M.; McGinnis, J. P.; Rabindran, S. K. Pyrazolo[1,5-a]pyrimidin-7-yl Phenyl Amides as Novel Anti-Proliferative Agents: Parallel Synthesis for Lead Optimization of Amide Region. Bioorg. Med Chem. Lett. 2005, 15(6), 1591–1594. https://doi.org/10.1016/j.bmcl.2005.01.066.
- Džimbeg, G.; Zorc, B.; Kralj, M.; Ester, K.; Pavelić, K.; Andrei, G.; Snoeck, R.; Balzarini, J.; Clercq, E. D.; Mintas, M. The Novel Primaquine Derivatives of N-Alkyl, Cycloalkyl or Aryl Urea: Synthesis, Cytostatic and Antiviral Activity Evaluations. Eur. J. Med. Chem. 2008, 43(6), 1180–1187. https://doi.org/10.1016/j.ejmech.2007.09.001.
- Saeed, S.; Rashid, N.; Jones, P. G.; Muhammad, A.; Hussain, R. Synthesis, Characterization and Biological Evaluation of Some Thiourea Derivatives Bearing Benzothiazole Moiety as Potential Antimicrobial and Anticancer Agents. Eur. J. Med. Chem. 2010, 45(4), 1323–1331. https://doi.org/10.1016/j.ejmech.2009.12.016.
- Ghorab, M. M.; Alsaid, M. S.; El-Gaby, M. S. A.; Safwat, N. A.; Elaasser, M. M.; Soliman, A. M. Biological Evaluation of Some New N-(2,6-Dimethoxypyrimidinyl) Thioureido Benzenesulfonamide Derivatives as Potential Antimicrobial and Anticancer Agents. Eur. J. Med. Chem. 2016, 124, 299–310. https://doi.org/10.1016/j.ejmech.2016.08.060.
- Faidallah, H. M.; Al-Saadi, M. S.; Rostom, S. A. F.; Fahmy, H. T. Y. Synthesis of Some Sulfonamides, Disubstituted Sulfonylureas or Thioureas and Some Structurally Related Variants. A Class of Promising Antitumor Agents. Med. Chem. Res. 2007, 16(6), 300–318. https://doi.org/10.1007/s00044-007-9033-8.
- Ismail, Z. H.; Ghorab, M. M.; Mohammed, E. M. A.; Aly, H. M.; El-Gaby, M. S. A. Antitumor Activity of Some Novel 1,2,5-Thiadiazole Derivatives. Phosphorus, Sulfur Silicon Relat. Elem. 2008, 183, 2541–2554. https://10.1080/10426500801967815.
- Türk, S.; Tok, F.; Çelik, H.; Karakuş, S.; Nadaroğlu, H.; Koçyiğit-Kaymakçıoğlu, B.; Küçükoğlu, K. Some N-(5-Methyl-1,3,4-Thiadiazol-2-yl)-4-[(3-Substituted)Ureido/thioureido]benzene-sulfonamides as Carbonic Anhydrase I and II Inhibitors. Marmara Pharm. J. 2017, 21, 89–95. https://doi.org/10.12991/marupj.259885.
- Karakuş, S.; Küçükgüzel, Ş. G.; Küçükgüzel, İ.; Clercq, E. D.; Pannecouque, C.; Andrei, G.; Snoeck, R.; Şahin, F.; Bayrak, Ö. F. Synthesis, Antiviral and Anticancer Activity of Some Novel Thioureas Derivedfrom N-(4-Nitro-2-Phenoxyphenyl)-Methanesulfonamide. Eur. J. Med. Chem. 2009, 44, 3591–3595. https://doi.org/10.12991/marupj.259885.
- Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Adv. Drug Deliv. Rev. 2001, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0.
- Veber, D. F.; Johnson, S. R.; Cheng, H. Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem. 2002, 45, 2615–2623. https://doi.org/10.1021/jm020017n.
- Egan, W. J.; Merz, K. M.; Baldwin, J. J. Prediction of Drug Absorption Using Multivariate Statistics. J. Med. Chem. 2000, 43, 3867–3877. https://doi.org/10.1021/jm000292e.
- Dassault Systemes BIOVIA, Discovery Studio Modeling Environment Release 2017. Dassault Systèmes: San Diego, 2016.
- Garza-Cervantes, J. A.; Chávez-Reyes, A.; Castillo, E. C.; García-Rivas, G.; Ortega-Rivera, O. A.; Salinas, E.; Ortiz-Martinez, M.; Gomez-Florez, S. L.; Pena-Martinez, J. A.; Pepi-Molina, A.; Trevino-Gonzalez, M. T.; Zarate, X.; Cantu-Cardenas, M. E.; Escarcega-Gonzalez, C. E.; Morones-Ramirez, J. R. Synergistic Antimicrobial Effects of Silver/Transition-Metal Combinatorial Treatments. Sci. Rep. 2017, 7(903), 1–16. https://doi.org/10.1038/s41598-017-01017-7.
- Ali-Boucetta, H.; Al-Jamal, K. T.; Kostarelos, K. Cytotoxic Assessment of Carbon Nanotube Interaction with Cell Cultures. Biomed. Nanotechnol. 2011, 726, 229–312. https://doi.org/10.1007/978-1-61779-052-2_19.